ResMed Inc (RMD)
218.57
-1.40
(-0.64%)
USD |
NYSE |
May 17, 16:00
218.62
+0.05
(+0.02%)
After-Hours: 20:00
ResMed Research and Development Expense (TTM): 304.81M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 304.81M |
| December 31, 2023 | 304.17M |
| September 30, 2023 | 300.16M |
| June 30, 2023 | 287.64M |
| March 31, 2023 | 273.82M |
| December 31, 2022 | 264.18M |
| September 30, 2022 | 256.81M |
| June 30, 2022 | 253.58M |
| March 31, 2022 | 249.13M |
| December 31, 2021 | 238.27M |
| September 30, 2021 | 230.70M |
| June 30, 2021 | 225.28M |
| March 31, 2021 | 217.93M |
| December 31, 2020 | 213.44M |
| September 30, 2020 | 208.45M |
| June 30, 2020 | 201.95M |
| March 31, 2020 | 200.56M |
| December 31, 2019 | 196.72M |
| September 30, 2019 | 189.89M |
| June 30, 2019 | 180.65M |
| March 31, 2019 | 169.17M |
| December 31, 2018 | 158.99M |
| September 30, 2018 | 156.52M |
| June 30, 2018 | 155.15M |
| March 31, 2018 | 152.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 149.89M |
| September 30, 2017 | 147.44M |
| June 30, 2017 | 144.47M |
| March 31, 2017 | 142.15M |
| December 31, 2016 | 135.12M |
| September 30, 2016 | 125.90M |
| June 30, 2016 | 118.65M |
| March 31, 2016 | 112.79M |
| December 31, 2015 | 111.71M |
| September 30, 2015 | 112.03M |
| June 30, 2015 | 114.86M |
| March 31, 2015 | 118.14M |
| December 31, 2014 | 120.64M |
| September 30, 2014 | 120.89M |
| June 30, 2014 | 118.23M |
| March 31, 2014 | 117.82M |
| December 31, 2013 | 119.48M |
| September 30, 2013 | 120.27M |
| June 30, 2013 | 120.12M |
| March 31, 2013 | 116.65M |
| December 31, 2012 | 113.86M |
| September 30, 2012 | 110.75M |
| June 30, 2012 | 109.73M |
| March 31, 2012 | 108.80M |
| December 31, 2011 | 103.72M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
180.65M
Minimum
Jun 2019
304.81M
Maximum
Mar 2024
239.91M
Average
234.49M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| Align Technology Inc | 351.24M |
| Stryker Corp | 1.417B |
| Haemonetics Corp | 54.44M |
| Teleflex Inc | 150.18M |